Massive study hints diabetes drug may shield brain from dementia
NCT ID NCT05768945
First seen Nov 11, 2025 · Last updated May 15, 2026 · Updated 18 times
Summary
This study looked at medical records from over 740,000 older adults with diabetes to see if a drug called semaglutide (used for diabetes) might lower the risk of developing dementia or Alzheimer's disease. Researchers compared people taking semaglutide to those taking other diabetes drugs. The goal was to find out if semaglutide could be repurposed to protect the brain, but this was a data analysis, not a treatment trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.